Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Arrowhead Pharmaceuticals Inc ARWR
$76.67
▼ -3.79%
($-3.02)
Open
$78.16
Prev Close
$79.69
Day Range
$76.26 – $79.00
52W Range
$14.30 – $82.26
Market Cap
$10.80B
Beta
1.26
EPS (TTM)
$-2.15
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1993-12-14 |
| Shares Out. | 140,030,000 |
| Website | arrowheadpharma.com/ ↗ |
| Phone | 13026974590 |
Arrowhead Pharmaceuticals Inc is a publicly traded company under the ticker symbol ARWR on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
19 analysts (2026-05-01)
📰 Latest News for ARWR
Transcript : Arrowhead Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 through May-14-2026
Arrowhead Pharmaceuticals : ECO 2026 LBP4078 Kerr Activin E Poster 6May2026 FINAL
Arrowhead Pharmaceuticals Eyes $4B REDEMPLO Opportunity as RNAi Pipeline Readouts Near
Arrowhead Pharmaceuticals : TIDES 2026 KM final (1)
Bernstein Maintains Market Perform on Arrowhead Pharma, Raises Price Target to $46
Assessing Arrowhead Pharmaceuticals (ARWR) Valuation After Its Recent Share Price Momentum
Arrowhead Pharmaceuticals: A True Inflection Point Has Arrived